SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000908834-24-000059
Filing Date
2024-02-13
Accepted
2024-02-13 15:41:49
Documents
1

Document Format Files

Seq Description Document Type Size
1 rare_13g.htm SC 13G 53692
  Complete submission text file 0000908834-24-000059.txt   55616
Mailing Address SANDS CAPITAL MANAGEMENT, LLC 1000 WILSON BLVD, SUITE 3000 ARLINGTON VA 22209
Business Address SANDS CAPITAL MANAGEMENT, LLC 1000 WILSON BLVD, SUITE 3000 ARLINGTON VA 22209 703-562-4000
SANDS CAPITAL MANAGEMENT, LLC (Filed by) CIK: 0001020066 (see all company filings)

IRS No.: 202830751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Subject) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87964 | Film No.: 24625345
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)